Journal of Veterinary Cardiovascular Medicine
Online ISSN : 2432-5392
Volume 3, Issue 2
Displaying 1-3 of 3 articles from this issue
Clinical note
  • Michio Katagi
    Article type: Clinical note
    2019 Volume 3 Issue 2 Pages 23-28
    Published: December 30, 2019
    Released on J-STAGE: December 30, 2019
    JOURNAL OPEN ACCESS

    A mosaic color pattern of the left ventricular outflow tract by color Doppler echocardiography can be found in conditions such as dynamic left ventricular outflow tract obstruction due to hypertrophic cardiomyopathy and deformation or hypertrophy of mitral valve leaflets, chordae tendineae, and/or papillary muscles. One condition that can cause dynamic left ventricular outflow tract obstruction is systolic anterior motion (SAM) of the anterior leaflet of the mitral valve. The pathogenesis of SAM is still unknown. We encountered a cat that on initial presentation had a mosaic color pattern without myocardial hypertrophy (a left ventricular wall measuring less than 6 mm thick in diastole). At 299 days, papillary muscle hypertrophy had manifested. Myocardial hypertrophy was confirmed at 359 days. This report documents the clinical history of this cat.

    Download PDF (688K)
  • Asako Shinoda, Hiroyasu Masaki, Masami Uechi
    Article type: Clinical note
    2019 Volume 3 Issue 2 Pages 29-33
    Published: December 30, 2019
    Released on J-STAGE: December 30, 2019
    JOURNAL OPEN ACCESS

    Postoperative pulmonary hypertension upon weaning off from cardiopulmonary bypass occurs due to lung ischemia-reperfusion injury. Ischemic injury from deprivation of blood flow to the lungs, stimulation of neutrophils by the cardiopulmonary bypass, and complement activation leading to systemic inflammatory response contribute to the pathogenesis of lung ischemia-reperfusion injury. We report a canine patient that developed a severe pulmonary hypertension following mitral valve repair. On postoperative day 3, respiratory rate had increased and chest x-ray revealed increased opacity. Echocardiographic findings were severe tricuspid regurgitation and severe pulmonary hypertension. Clinical signs improved following the administration of sildenafil, diuretics and pimobendan, and the patient was discharged. However, upon discontinuation of sildenafil, respiratory distress has returned so the patient was placed back on sildenafil. Sildenafil has been used to decrease pulmonary hypertension after open heart surgery in humans. This patient developed severe pulmonary hypertension despite the marked reduction in mitral valve regurgitation postoperatively, the following factors were considered: endothelial cell dysfunction, hypoxic pulmonary vasoconstriction, pulmonary vasoconstriction mediated by sympathetic stimulation following general anesthesia. This patient responded well to oral sildenafil and we can suggest that sildenafil is an effective agent for treatment of pulmonary hypertension following cardiac surgery in dogs.

    Download PDF (301K)
From ACVMS
  • 2019 Volume 3 Issue 2 Pages 34-
    Published: December 30, 2019
    Released on J-STAGE: December 30, 2019
    JOURNAL OPEN ACCESS
    Download PDF (52K)
feedback
Top